Dexamethasone Attenuates LPS-induced Acute Lung Injury through Inhibition of NF-κB, COX-2, and Pro-inflammatory Mediators

Immunological Investigations

Volumn 45, Issue 4, 2016, Pages 349-369

  Al Harbi, Naif O ^a   Imam, Faisal ^a   Al Harbi, Mohammed M ^a   Ansari, Mushtaq Ahmad ^a   Zoheir, Khairy M A ^a   Korashy, Hesham M ^a   Sayed Ahmed, Mohamed M ^a   Attia, Sabry M ^a   Shabanah, Othman A ^a   Ahmad, Sheikh Fayaz ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Cytokines; dexamethasone; inflammatory mediators; lipopolysaccharides; nuclear factor kappa B; T cell receptors

Indexed keywords

AUTACOID; CYCLOOXYGENASE 2; DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ACUTE LUNG INJURY; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; LUNG; MALE; METABOLISM; MOUSE; NEUTROPHIL; PATHOLOGY; SIGNAL TRANSDUCTION;

ACUTE LUNG INJURY; ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2; DEXAMETHASONE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED BALB C; NEUTROPHILS; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84964495106     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2016.1157814     Document Type: Article

References (82)

1. Abraham E. (2003). Neutrophils and acute lung injury. Crit Care Med, 31, S195-9.
2. Abraham E, Carmody A, Shenkar R, et al. (2000). Neutrophils as early immunologic effectors in hemorrhage or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol, 279, L1137-45.
3. Adcock IM, Caramori G. (2001). Cross-talk between pro-inflammatory transcription factors and glucocorticoids, Immunol Cell Biol, 79(4), 376-84.
4. Ahmad SF, Zoheir KM, Abdel-Hamied HE, et al. (2014a). Amelioration of autoimmune arthritis by naringin through modulation of T regulatory cells and Th1/Th2 cytokines. Cell Immunol, 287, 112-20.
5. Ahmad SF, Zoheir KM, Ansari MA, et al. (2015). The role of poly (ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice. Mol Immunol, 63: 394-405.
6. Ahmad SF, Zoheir KM, Bakheet SA, et al. (2014b). Poly (ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model. Cytokine, 68, 76-85.
7. Al-Harbi, N.O., Imam, F., Nadeem, A., et al. (2015). Riboflavin attenuates lipopolysaccharideinduced lung injury in rats. Toxicol Mech Methods, 25, 417-23.
8. Annane, D. (2005). Low-dose adrenocorticotropic hormone test is not ready for routine adrenal function testing in the intensive care unit. Crit Care Med, 33, 2688-9.
9. Annane D, Sebille V, Charpentier C, et al. (2002). Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA., 288, 862-71.
10. Ansari MA, Maayah ZH, Bakheet SA, et al. (2013). The role of aryl hydrocarbon receptor signaling pathway in cardiotoxicity of acute lead intoxication in vivo and in vitro rat model. Toxicology, 306, 40-49.
11. Barakat A, Szick-Miranda K, Chang IF, et al. (2001). The organization of cytoplasmic ribosomal protein genes in the Arabidopsis genome. Plant Physiol, 127(2), 398-415.
12. Baughman RP, Gunther KL, Rashkin MC, et al. (1996). Changes in the inflammatory response of the lung during acute respiratory distress syndrome: Prognostic indicators. Am J Respir Crit Care Med, 154, 76-81.
13. Bernard GR, Artigas A, Brigham KL, et al. (1994). The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med, 149, 818-24.
14. Berry LJ, Smythe DS. (1964). Effects of bacterial endotoxins on metabolism. VII. Enzyme induction and cortisone protection. J Exp Med, 120, 721-32.
15. Chen J, Wang JB, Yu CH, et al. (2013). Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice. J. Ethnopharmacol, 148, 835-841.
16. Chen Z, Zhang X, Chu X, et al. (2010). Preventive effects of valnemulin on lipopolysaccharide induced acute lung injury in mice. Inflammation, 33, 306-14.
17. Chiara O, Giomarelli PP, Casini A. (1989). Acute lung injury: Role of lipid peroxidation. Update Intensive Care Emerg Med, 8, 33-8.
18. Chow CW, Herrera Abreu MT, Suzuki T, et al. (2003). Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol, 29, 427-31.
19. De Campos T (2000). Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med, 342, 1301-8.
20. De Kozak Y, Thillaye-Goldenberg B, Naud MC, et al. (2002). Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene. Clin Exp Immunol, 130, 212-23.
21. Di R, Huang MT, Ho CT. (2011). Anti-inflammatory activities of mogrosides from Momordica grosvenori in murine macrophages and a murine ear edema model. J Agric Food Chem, 59, 7474-81.
22. Eickmeier O, Seki H, Haworth O, et al. (2013). Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. Mucosal Immunol, 6, 256-66.
23. El Kebir D, Jozsef L, Pan W, et al. (2008). Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation. Circ Res, 103, 352-9.
24. Fabiani JN, Camilleri JP. (1986). Membrane modifications in myocardial infarction following emergency reperfusion. Ann Cardiol Angeiol, 35, 439-46.
25. Feng L, Xia Y, Garcia GE, et al. (1995). Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest, 95, 1669-75.
26. Friedman GB, Taylor CT, Parkos CA, et al. (1998). Epithelial permeability induced by neutrophil transmigration is potentiated by hypoxia: Role of intracellular cAMP. J Cell Physiol, 176, 76-84.
27. Giebelen IA, van Westerloo DJ, LaRosa GJ, et al. (2007). Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock, 28, 700-703.
28. Gonzalez-Lopez A, Albaiceta GM. (2012). Repair after acute lung injury: Molecular mechanisms and therapeutic opportunities. Crit Care, 16, 1-7.
29. Goulding NJ. (2004). The molecular complexity of glucocorticoid actions in inflammation a fourring circus. Curr Opin Pharmacol, 4, 629-36.
30. Grommes J, Soehnlein O. (2011). Contribution of neutrophils to acute lung injury. Mol Med, 17, 293-307.
31. Gust R, Kozlowski JK, Stephenson AH, et al. (1999). Role of cyclooxygenase-2 in oleic acid-induced acute lung injury. Am. J. Respir. Crit Care Med, 160, 1165-70.
32. Handel ML. (1997). Transcription factors AP-1 and NF-κB: Where steroids meet the gold standard of anti-rheumatic drugs. Inflammation Research, 46, 282-6.
33. Hernandez ML, Harris B, Lay JC, et al. (2010). Comparative airway inflammatory response of normal volunteers too zone and lipopolysaccharide challenge. Inhal Toxicol, 22, 648-56.
34. Hernandez ML, Herbst M, Lay JC, et al. (2012). Atopic asthmatic patients have reduced airway inflammatory cell recruitment after inhaled endotoxin challenge compared with healthy volunteers. J Allergy Clin Immunol, 130, 869-76.
35. Hernandez ML, Wagner JG, Kala A, et al. (2013). Vitamin E, g-tocopherol, reduces airway neutrophil recruitment after inhaled endotoxin challenge in rats and in healthy volunteers. Free Radic Biol Med, 60, 56-62.
36. Impellizzeri D, Esposito E, Mazzon E, et al. (2011). Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. Biochem Pharmacol, 81, 636-48.
37. Ivanova AV, Mikhal'chik EV, Miroshnikova EA, et al. (2006). Effect of endotoxemia on skin antioxidant enzymes under experimental conditions. B Exp Biol Med, 142, 413-5.
38. Jing W, Chunhua M, Shumin W. (2015). Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro. Toxicol Appl Pharmacol, 285, 128-35.
39. Joyce DA, Gimblett G, Steer JH. (2001). Targets of glucocorticoid action on TNF-alpha release by macrophages. Inflammation Res, 50, 337-40.
40. Kilpatrick LE, Standage SW, Li H, et al. (2011). Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-δ (δ-PKC). J Leukoc Biol, 89, 3-10.
41. Kim SO, Kundu JK, Shin YK, et al. (2005). [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene, 24, 2558-67.
42. Knapp S, Florquin S, Golenbock DT, et al. (2006). Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo. J Immunol, 176, 3189-95.
43. Knowles RG, Salter M, Brooks SL, et al. (1990). Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun, 172, 1042-8.
44. Kobayashi A, Hashimoto S, Kooguchi K, et al. (1998). Expression of inducible nitric oxide synthase and inflammatory cytokines in alveolar macrophages of ARDS following sepsis. Chest, 113, 1632-9.
45. Kumar RK, Herbert C, Thomas PS, et al. (2003). Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J Pharmacol Exp Ther, 307, 349-55.
46. Laight DW, Lad N, Woodward B, et al. (1994). Assessment of myeloperossidase activity in renal tissue after ischemia-reperfusion. Eur J Pharmacol, 292, 81-8.
47. Lowry OH, Rosenburg NJ, Farr AL, et al. (1951). Protein measurement with Folin phenol reagent. J Biol Chem, 193, 265-75.
48. Matthay, MA, Zimmerman GA, Esmon C, et al. (2003). Future research directions in acute lung injury. Am J Respir Crit Care Med, 167, 1027-35.
49. McGuire SR, Hoesel LM, Ipaktchi K, et al. (2008). Acute lung injury induced by lipopolysaccharide is independent of complement activation. J Immunol, 180), 7664-72.
50. Minamino T, Komuro I. (2006). Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury. J Clin Invest, 116, 2316-9.
51. Moine P, McIntyre R, Schwartz MD, et al. (2000). NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock, 13, 85-91.
52. Moore KW, Rousset F, Banchereau J. (1991). Evolving principles in immunopathology: Interleukin 10 and its relationship to Epstein-Barr virus protein BCRF1. Springer Semin Immunopathol, 13, 157-66.
53. Morote-Garcia JC, Napiwotzky D, Kohler D, et al. (2012). Endothelial Semaphorin 7A promotes neutrophil migration during hypoxia. Proc Natl Acad Sci USA, 109, 14146-51.
54. Morris PE, Glass J, Cross R, et al. (1997). Role of T-lymphocytes in the resolution of endotoxininduced lung injury. Inflammation, 21, 269-78.
55. Pham CT. (2006). Neutrophil serine proteases: Specific regulators of inflammation. Nat Rev Immunol, 6, 541-50.
56. Philippakis GE, Lazaris AC, Papathomas TG, et al. (2008). Adrenaline attenuates the acute lung injury after intratracheal lipopolysaccharide instillation: An experimental study. Inhal Toxicol, 20, 445-53.
57. Razavi HM, Werhun R, Scott JA, et al. (2002). Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury. Crit Care Med, 30, 868-73.
58. Rhen T, Cidlowski JA. (2005). Antiinflammatory action of glucocorticoids new mechanisms for old drugs. N Eng J Med, 353, 1711-23.
59. Rocksen D, Lilliehook B, Larsson R, et al. (2000). Differential anti-inflammatory and anti-oxidative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation. Clin Exp Immunol, 122, 249-56.
60. Rubenfeld GD. (2003). Epidemiology of acute lung injury. Crit Care Med, 31, 276-84.
61. Saklatvala J. (2002). Glucocorticoids: Do we know how they work? Arthritis Res, 4, 146-50.
62. Saraiva M, O'Garra A. (2010). The regulation of IL-10 production by immune cells. Nat Rev Immunol, 10, 170-81.
63. Sedlack J, Lindsay RH. (1968). Estimation of total, protein bound and non-protein bound sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem, 25, 192-205.
64. Serou, MJ, DeCoster MA, Bazan NG. (1999). Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Plateletactivating factor as a preferential mediator of cyclooxygenase-2 expression. J Neurosci Res, 58, 593-8.
65. Shinbori T, Walczak H, Krammer PH. (2004). Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-α. Eu J Immunol, 34, 1762-70.
66. Soromou LW, Chu X, Jiang L, et al. (2012). In vitro and in vivo protection provided by pinocembrin against lipopolysaccharide-induced inflammatory responses. Int Immunopharmacol, 14, 66-74.
67. Spink WW, Anderson D. (1954). Experimental studies on the significance of endotoxin in the pathogenesis of brucellosis. J Clin Invest, 33, 540-8.
68. Strandberg Y, Gray C, Vuocolo T, et al. (2005). Lipopolysaccharide and lipoteichoic acid induce different innate immune responses in bovine mammary epithelial cells. Cytokine, 31, 72-86.
69. Till GO, Hatherill JR, Tourtellotte WW, et al. (1985). Lipid peroxidation and acute lung injury after thermal trauma to skin. Evidence of a role for hydroxyl radical. Am J Pathol, 119, 376-84.
70. Tipoe GL, Leung TM, Liong E, et al. (2006). Inhibitors of inducible nitric oxide (NO) synthase are more effective than an NO donor in reducing carbon-tetrachloride induced acute liver injury. Histol Histopathol, 21, 1157-65.
71. Tough DF, Sun S, Sprent J. (1997). T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med, 185, 2089-94.
72. Trifilieff A, Fujitani Y, Mentz F, et al. (2000). Inducible nitric oxide synthase inhibitors suppresses airway inflammation in mice through downregulation of chemokine expression. J Immunol, 165, 1526-33.
73. Tsurufuji S, Sugio K, Takemasa F. (1979). The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature, 280, 408-10.
74. Van Putte BP, Kesecioglu J, Hendriks JM, et al. (2005). Cellular infiltrates and injury evaluation in a rat model of warm pulmonary ischemia-reperfusion. Crit Care, 9, R1-8.
75. Vernooy JH, Dentener MA, van Suylen RJ, et al. (2001). Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells: No role for tumor necrosis factoralpha and infiltrating neutrophils. Am J Resp Cell Mol Biol, 24, 569-76.
76. Ward PA. (1996). Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann N Y Acad Sci, 796, 104-12.
77. Wizemann TM, Gardiner CR, Laskin JD, et al. (1994). Production of nitric oxide and peroxynitrite in the lung during endotoxemia. J Leukoc Biol, 56, 759-68.
78. Wood LG, Gibson PG, Garg ML. (2003). Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J, 21, 177-86.
79. Yates DT, Loest CA, Ross TT, et al. (2011). Effects of bacterial lipopolysaccharide injection on white blood cell counts, hematological parameters, and serum glucose, insulin, and cortisol concentrations in ewes fed low or high protein diets. J Anim Sci, 89, 4286-93.
80. Yingkun N, Zhenyu W, Jing L, et al. (2013). Stevioside protects LPS-induced acute lung injury in mice. Inflammation, 36, 242-50.
81. Yu Z, Ouyang JP, Li YP. (2009). Dexamethasone attenuated endotoxin-induced acute lung injury through inhibiting expression of inducible nitric oxide synthase. Clin Hemorheol Micro, 41, 117-25.
82. Zhu J, Paul WE. (2008). CD4 T cells: fates, functions, and faults. Blood, 112, 1557-69.